Citation Impact
Citing Papers
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
2003 StandoutScience
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Immunological aspects of cancer chemotherapy
2007
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion
2000
MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
1999
Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment
2009
Principals of neovascularization for tissue engineering
2002
Testicular Germ-Cell Cancer
1997 Standout
Robotic resection compared with laparoscopic rectal resection for cancer: systematic review and meta‐analysis of short‐term outcome
2011
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
2005 StandoutNobel
Genital human papillomavirus infection in men
2005
Tadalafil Administered Once Daily for Treatment of Lower Urinary Tract Symptoms in Korean men with Benign Prostatic Hyperplasia: Results from a Placebo‐Controlled Pilot Study Using Tamsulosin as an Active Control
2011
Function of the c-Myc Oncogenic Transcription Factor
1999
Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men With or Without Erectile Dysfunction
2010
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
Activating c-kit Gene Mutations in Human Germ Cell Tumors
1999
Erectile Dysfunction
2000 Standout
Nociceptive Signals Induce Trafficking of TRPA1 to the Plasma Membrane
2009 StandoutNobel
Characterization and Functional Role of Androgen-Dependent PDE5 Activity in the Bladder
2006
Intracavernous prostaglandin E1 in erectile dysfunction
1994
Short‐ and long‐term complications of open radical prostatectomy according to the Clavien classification system
2008
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial
2011
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII
2011
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors
2005 Standout
Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia
2009
Colorectal cancer
2013 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
2011
The next generation of PDE4 inhibitors
2001
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
2011
Epigenetics in cancer
2009 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250
2000
Change in quality of life of medically hospitalized patients – A one-year follow-up study
2012
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Human papillomavirus and cervical cancer
2007 Standout
Depression and Quality of Life in Older Persons: A Review
2015 Standout
Oral Sildenafil in the Treatment of Erectile Dysfunction
1998 Standout
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Tamsulosin
1996
Efficacy and Safety of Intracavernosal Alprostadil in Men with Erectile Dysfunction
1996
Novel approaches in the therapy of metastatic renal cell carcinoma
2005
Molecular genetics of prostate cancer
2000
Chapter 9: Role of Mucosal Human Papillomavirus in Nongenital Cancers
2003
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Long-term functional and oncological results after retroperitoneal laparoscopic prostatectomy according to a prospective evaluation of 550 patients
2006
Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells
1998
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
2005
Cancer immunotherapy comes of age
2011 StandoutNature
Transperitoneal versus extraperitoneal laparoscopic radical prostatectomy: Experience of a single center
2006
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
The effect of sildenafil citrate on bladder outlet obstruction: a mouse model
2008
RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma
2008
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
2013
Molecular mechanisms of carbonic anhydrase IX‐mediated pH regulation under hypoxia
2008 StandoutNobel
The role of senescent cells in ageing
2014 StandoutNature
Idiopathic pulmonary fibrosis
2011 Standout
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Phosphodiesterase-5 Inhibitors for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
2011
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Cancer immunotherapy with mRNA‐transfected dendritic cells
2004
Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial
2012
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Fluorine in medicinal chemistry
2007 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Sorafenib for the Treatment of Advanced Renal Cell Carcinoma
2006
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Role of Cytokine Therapy in 2006 and Beyond for Metastatic Renal Cell Cancer
2006
INTRACAVERNOUS INJECTION THERAPY FOR MALE ERECTILE DYSFUNCTION
1995
The Rationale for Prostaglandin E1 in Erectile Failure: A Survey of Worldwide Experience
1996
Caveolin-1 Maintains Activated Akt in Prostate CancerCells through Scaffolding Domain Binding Site Interactions with andInhibition of Serine/Threonine Protein Phosphatases PP1 andPP2A
2003
Randomized Phase II/III Trial of Interferon Alfa-2a With and Without 13-cis-Retinoic Acid in Patients With Progressive Metastatic Renal Cell Carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)
2005
Urodynamic Effects of Once Daily Tadalafil in Men With Lower Urinary Tract Symptoms Secondary to Clinical Benign Prostatic Hyperplasia: A Randomized, Placebo Controlled 12-Week Clinical Trial
2010
Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.
2003
Complications of 2,775 Urological Laparoscopic Procedures: 1993 to 2005
2007
Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
1997
Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.
2003
Tumor cell senescence in cancer treatment.
2003
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes
1998
The Max Network Gone Mad
2001
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Tumor‐associated Carbonic Anhydrases and Their Clinical Significance
2006
Genital Human Papillomavirus Infection in Men
2007
Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study
2008
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Postchemotherapy Retroperitoneal Surgery Remains Necessary in Patients With Nonseminomatous Testicular Cancer and Minimal Residual Tumor Masses
2003
Phosphodiesterase Type 5 Expression in Human and Rat Lower Urinary Tract Tissues and the Effect of Tadalafil on Prostate Gland Oxygenation in Spontaneously Hypertensive Rats
2011
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Therapeutic effects of monoclonal antibody g250, interferons and tumor necrosis factor, in mice with renal‐cell carcinoma xenografts
1994
Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
2007
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Udo Jonas being referenced
The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
1998
RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis
2007
Management of the post-chemotherapy residual mass in patients with advanced stage non-seminomatous germ cell tumors (nsgct)
1999
Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future
2006
Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients
2006
Immunohistochemical Distribution of cAMP- and cGMP-Phosphodiesterase (PDE) Isoenzymes in the Human Prostate
2006
Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours
1996
Categorisation of complications of endoscopic extraperitoneal and laparoscopic transperitoneal radical prostatectomy
2006
Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer
2006
Evolution of endoscopic extraperitoneal radical prostatectomy (EERPE)?technical improvements and development of a nerve-sparing, potency-preserving approach
2003
Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle
1997
Tissue engineering from Adam to the zygote: historical reflections
2000
Effects of Phosphodiesterase Inhibitors on Tension Induced by Norepinephrine and Accumulation of Cyclic Nucleotides in Isolated Human Prostatic Tissue
2008
Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features
2001
The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms
2008
Die endoskopische extraperitoneale radikale Prostatektomie (EERPE)
2004
Detection of viral HPV 16 DNA in prostate cancer and benign prostatic hyperplasia by quantitative PCR-directed analysis
2000
The current status of robotic pelvic surgery: results of a multinational interdisciplinary consensus conference
2008
Adiposity and Age are Statistically Related to EnhancedRASSF1ATumor Suppressor Gene Promoter Methylation in Normal Autopsy Kidney Tissue
2007
Predictive Value of Real-Time Rigiscan Monitoring for the Etiology of Organogenic Impotence
1993
Complete spontaneous regression in metastatic renal cell carcinoma — an update and review
1991
ENDOSCOPIC EXTRAPERITONEAL RADICAL PROSTATECTOMY: ONCOLOGICAL AND FUNCTIONAL RESULTS AFTER 700 PROCEDURES
2005
New methods in the diagnosis of impotence: RigiScan� penile tumescence and rigidity monitoring and diagnostic papaverine hydrochloride injection
1987
Calcitonin-Gene-Related Peptide: A Possible Role in Human Penile Erection and its Therapeutic Application in Impotent Patients
1991
Endoscopic Extraperitoneal Radical Prostatectomy: Initial Experience after 70 Procedures
2003
Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma.
1986
Followup Results of a Combination of Calcitonin Gene-Related Peptide and Prostaglandin E1 in the Treatment of Erectile Dysfunction
1993
Current clinical relevance of immunotherapy in metastatic renal cell cancer
1991
822: Endoscopic Extraperitoneal Radical Prostatectomy (EERPE) - Experience After 300 Cases
2004
The Impact of Nocturia on Health Status and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
2004
Monoclonal antibody G 250 recognizes a determinant present in renal‐cell carcinoma and absent from normal kidney
1986
Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers.
1999
Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer
2001
Preliminary report on the effect of the nitric oxide donor SIN-1 on human cavernous tissue in vivo
1991
Interleukin-2- and Interferon Alfa-2a-Based Immunochemotherapy in Advanced Renal Cell Carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
2004
CHARACTERIZATION AND FUNCTIONAL RELEVANCE OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOENZYMES OF THE HUMAN PROSTATE
2001
Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group.
1996
EXPRESSION OF DIFFERENT PHOSPHODIESTERASE GENES IN HUMAN CAVERNOUS SMOOTH MUSCLE
2001
BIOLOGICAL VASCULARIZED MATRIX FOR BLADDER TISSUE ENGINEERING: MATRIX PREPARATION, RESEEDING TECHNIQUE AND SHORT-TERM IMPLANTATION IN A PORCINE MODEL
2005